Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashanth Patel

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Pharmacology Research & Perspectives|February 11, 2021
Achieving optimal adherence to medical therapy by telehealth: Findings from the ORBITA medication adherence sub-studyDavid Thompson, Rasha Al-Lamee, Michael Foley, et al.
Clinical Medicine (London, England)|April 9, 2026
Dyslipidaemia and cardiovascular risk - key considerations in South AsiansAneesha Chauhan, Shaan Sahota, Lavandan Jegatheeswaran, et al.
JMIR Research Protocols|November 15, 2018
The Ready to Reduce Risk (3R) Study for a Group Educational Intervention With Telephone and Text Messaging Support to Improve Medication Adherence for the Primary Prevention of Cardiovascular Disease: Protocol for a Randomized Controlled TrialJo L Byrne, Helen M Dallosso, Stephen Rogers, et al.
JMIR Research Protocols|July 26, 2019
Corrigendum and Editorial Warning Regarding Use of the MMAS Scale (The Ready to Reduce Risk (3R) Study for a Group Educational Intervention With Telephone and Text Messaging Support to Improve Medication Adherence for the Primary Prevention of Cardiovascular Disease: Protocol for a Randomized Controlled Trial)Jo L Byrne, Helen M Dallosso, Stephen Rogers, et al.
Heart (British Cardiac Society)|April 4, 2014
High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysisMaciej Tomaszewski, Christobelle White, Prashanth Patel, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 28, 2022
High non-adherence rates to secondary prevention by chemical adherence testing in patients with TIADan Lane, Lucy Beishon, Vinoda Sharma, et al.
BMC Medicine|July 28, 2020
Effectiveness of the Ready to Reduce Risk (3R) complex intervention for the primary prevention of cardiovascular disease: a pragmatic randomised controlled trialJo L Byrne, Helen M Dallosso, Stephen Rogers, et al.
Plos Medicine|November 5, 2021
SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional studyChristopher A Martin, Colette Marshall, Prashanth Patel, et al.
Journal of Immunological Methods|May 2, 2021
Immunoglobulin isotype compositions of ABO specific antibodies are dependent on the individual patient blood group and blood group specificity: Results from a healthy donor cohortSunil Daga, Shimon Hussain, Nithya Krishnan, et al.
Journal of Public Health (Oxford, England)|December 28, 2020
No cases of asymptomatic SARS-CoV-2 infection among healthcare staff in a city under lockdown restrictions: lessons to inform 'Operation Moonshot'Christopher A Martin, David R Jenkins, Prashanth Patel, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Pharmacology Research & Perspectives|February 11, 2021
Achieving optimal adherence to medical therapy by telehealth: Findings from the ORBITA medication adherence sub-studyDavid Thompson, Rasha Al-Lamee, Michael Foley, et al.
Clinical Medicine (London, England)|April 9, 2026
Dyslipidaemia and cardiovascular risk - key considerations in South AsiansAneesha Chauhan, Shaan Sahota, Lavandan Jegatheeswaran, et al.
JMIR Research Protocols|November 15, 2018
The Ready to Reduce Risk (3R) Study for a Group Educational Intervention With Telephone and Text Messaging Support to Improve Medication Adherence for the Primary Prevention of Cardiovascular Disease: Protocol for a Randomized Controlled TrialJo L Byrne, Helen M Dallosso, Stephen Rogers, et al.
JMIR Research Protocols|July 26, 2019
Corrigendum and Editorial Warning Regarding Use of the MMAS Scale (The Ready to Reduce Risk (3R) Study for a Group Educational Intervention With Telephone and Text Messaging Support to Improve Medication Adherence for the Primary Prevention of Cardiovascular Disease: Protocol for a Randomized Controlled Trial)Jo L Byrne, Helen M Dallosso, Stephen Rogers, et al.
Heart (British Cardiac Society)|April 4, 2014
High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysisMaciej Tomaszewski, Christobelle White, Prashanth Patel, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 28, 2022
High non-adherence rates to secondary prevention by chemical adherence testing in patients with TIADan Lane, Lucy Beishon, Vinoda Sharma, et al.
BMC Medicine|July 28, 2020
Effectiveness of the Ready to Reduce Risk (3R) complex intervention for the primary prevention of cardiovascular disease: a pragmatic randomised controlled trialJo L Byrne, Helen M Dallosso, Stephen Rogers, et al.
Plos Medicine|November 5, 2021
SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional studyChristopher A Martin, Colette Marshall, Prashanth Patel, et al.
Journal of Immunological Methods|May 2, 2021
Immunoglobulin isotype compositions of ABO specific antibodies are dependent on the individual patient blood group and blood group specificity: Results from a healthy donor cohortSunil Daga, Shimon Hussain, Nithya Krishnan, et al.
Journal of Public Health (Oxford, England)|December 28, 2020
No cases of asymptomatic SARS-CoV-2 infection among healthcare staff in a city under lockdown restrictions: lessons to inform 'Operation Moonshot'Christopher A Martin, David R Jenkins, Prashanth Patel, et al.
Pageof 5